STRATA SKIN SCIENCES INC (SSKN) Stock Price, Quote, News and Overview
NASDAQ:SSKN - Nasdaq - US86272A3059 - Common Stock - Currency: USD
SSKN Quote, Performance and Key Statistics
NASDAQ:SSKN (4/25/2025, 8:00:00 PM)
2.59
-0.03 (-1.15%)
The current stock price of SSKN is 2.59 USD. In the past month the price decreased by -0.77%. In the past year, price decreased by -49.66%.
SSKN Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 26.96 | 223.47B | ||
| ISRG | INTUITIVE SURGICAL INC | 67.35 | 184.36B | ||
| BSX | BOSTON SCIENTIFIC CORP | 37.74 | 150.72B | ||
| SYK | STRYKER CORP | 29.95 | 139.34B | ||
| MDT | MEDTRONIC PLC | 15.76 | 107.94B | ||
| BDX | BECTON DICKINSON AND CO | 14.74 | 58.89B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.25 | 44.70B | ||
| IDXX | IDEXX LABORATORIES INC | 38.88 | 35.45B | ||
| RMD | RESMED INC | 25.98 | 34.64B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.24 | 31.33B | ||
| DXCM | DEXCOM INC | 43.43 | 28.10B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 15.84 | 23.53B |
Related stock screener links
About SSKN
Company Profile
STRATA Skin Sciences, Inc. is a medical technology company in Dermatology and Plastic Surgery. The company is headquartered in Horsham, Pennsylvania and currently employs 106 full-time employees. The company went IPO on 2005-10-28. The firm is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The firm operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.
Company Info
STRATA SKIN SCIENCES INC
5 Walnut Grove Dr Ste 140
Horsham PENNSYLVANIA 19044 US
CEO: Robert J. Moccia
Employees: 99
Company Website: https://www.strataskinsciences.com/
Investor Relations: http://melasciences.com/investors/home
Phone: 12156193200
STRATA SKIN SCIENCES INC / SSKN FAQ
What is the stock price of STRATA SKIN SCIENCES INC today?
The current stock price of SSKN is 2.59 USD. The price decreased by -1.15% in the last trading session.
What is the ticker symbol for STRATA SKIN SCIENCES INC stock?
The exchange symbol of STRATA SKIN SCIENCES INC is SSKN and it is listed on the Nasdaq exchange.
On which exchange is SSKN stock listed?
SSKN stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for STRATA SKIN SCIENCES INC stock?
8 analysts have analysed SSKN and the average price target is 10.2 USD. This implies a price increase of 293.82% is expected in the next year compared to the current price of 2.59. Check the STRATA SKIN SCIENCES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is STRATA SKIN SCIENCES INC worth?
STRATA SKIN SCIENCES INC (SSKN) has a market capitalization of 10.80M USD. This makes SSKN a Nano Cap stock.
How many employees does STRATA SKIN SCIENCES INC have?
STRATA SKIN SCIENCES INC (SSKN) currently has 99 employees.
What are the support and resistance levels for STRATA SKIN SCIENCES INC (SSKN) stock?
STRATA SKIN SCIENCES INC (SSKN) has a support level at 2.58 and a resistance level at 2.61. Check the full technical report for a detailed analysis of SSKN support and resistance levels.
Is STRATA SKIN SCIENCES INC (SSKN) expected to grow?
The Revenue of STRATA SKIN SCIENCES INC (SSKN) is expected to grow by 7.56% in the next year. Check the estimates tab for more information on the SSKN EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy STRATA SKIN SCIENCES INC (SSKN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of SSKN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of SSKN, evaluating the profitability, health, valuation and growth aspects
- STRATA SKIN SCIENCES INC (SSKN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- STRATA SKIN SCIENCES INC (SSKN) Sales and EPS estimates to see what analysts future expectations are.
- STRATA SKIN SCIENCES INC (SSKN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- STRATA SKIN SCIENCES INC (SSKN) Insider and Institutional Ownership to learn about the owners and their transactions.
- STRATA SKIN SCIENCES INC (SSKN) Stock Chart to make your own analysis
- STRATA SKIN SCIENCES INC (SSKN) Latest news and press-releases to stay up to date.
Does STRATA SKIN SCIENCES INC (SSKN) stock pay dividends?
SSKN does not pay a dividend.
When does STRATA SKIN SCIENCES INC (SSKN) report earnings?
STRATA SKIN SCIENCES INC (SSKN) will report earnings on 2025-04-28, after the market close.
What is the Price/Earnings (PE) ratio of STRATA SKIN SCIENCES INC (SSKN)?
STRATA SKIN SCIENCES INC (SSKN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.69).
What is the Short Interest ratio of STRATA SKIN SCIENCES INC (SSKN) stock?
The outstanding short interest for STRATA SKIN SCIENCES INC (SSKN) is 0.08% of its float. Check the ownership tab for more information on the SSKN short interest.
SSKN Technical Analysis
SSKN Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to SSKN. Both the profitability and financial health of SSKN have multiple concerns.
SSKN Financial Highlights
Over the last trailing twelve months SSKN reported a non-GAAP Earnings per Share(EPS) of -2.69. The EPS increased by 3.93% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -27.9% | ||
| ROE | -202.86% | ||
| Debt/Equity | 3.06 |
SSKN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 85% to SSKN. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of 61.29% and a revenue growth 7.56% for SSKN